From Rest to Rapidity
Historically, clinical practice emphasized mandatory rest periods between stimulated cycles to allow ovarian recovery. However, recent data suggests that the 'recovery' period is not strictly necessary for most patients, and in fact, long inter-cycle intervals may be counterproductive. Studies as recent as 2026 demonstrate that shorter intervals between stimulations correlate with improved embryological outcomes.
The DuoStim protocol—performing a follicular phase retrieval followed by a luteal phase retrieval within the same cycle—has emerged as a standard of care for poor prognosis patients. By condensing two cycles into one, practitioners significantly reduce the time to achieve a euploid blastocyst, directly addressing the clinical concern of patient attrition due to age-related decline.
Navigating Advanced Maternal Age (40+)
Patients aged 40+ face a specific set of biological hurdles, notably the reduced pool of recruitable follicles and the increased incidence of aneuploidy. While accelerated protocols like DuoStim effectively manage the 'number' of eggs, they cannot fully reverse the 'quality' decline.
In patients over 43, clinicians often encounter premature luteinization, where the follicular environment begins to age prematurely. Emerging strategies, such as triggering maturation at 16mm rather than the standard 18-20mm, represent targeted attempts to capture oocytes before the deleterious effects of the luteinizing hormone surge manifest.